Ascendis Pharma A/S(ASND)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
ASND is scheduled to report on Nov 9, 2026, after the market closes. Analysts expect EPS of $0.97.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±3.9%).
Did the stock rise after good news?
The next-day move after each of its last 3 EPS beats and 7 misses.
In plain words: it beat expectations 3 times, but the stock still fell 1 of those 3 times.
- Feb '26Missed▼ -1.5%
- Nov '25Missed▲ +3.6%
- Aug '25Beat▲ +0.6%
- May '25Missed▲ +2.7%
- Feb '25Beat▲ +13.0%
- Nov '24Missed▲ +1.8%
- Sep '24Missed▼ -11.3%
- May '24Missed▼ -2.8%
- Feb '24Beat▼ 0.0%
- Nov '23Missed▼ -1.5%
Clear beats and misses with a known reaction only. What counts as a beat
Why did ASND fall after beating earnings?
4 of ASND's last 10 reactions went against the EPS result. What stands out in each:
ASND beat EPS estimates in 3 quarters, and the stock still closed lower the next day 1 time.
- Feb 7, 2024EPS beat +12.5%stock 0.0% next day
- It had risen 7.2% in the final week before the report, so good news may already have been priced in.
- It opened 1.1% higher, but sellers took over and it closed 0.0%.
Rose despite an EPS miss (3 of 7)
- Nov 12, 2025EPS missed -733.3%stock +3.6% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- May 1, 2025EPS missed -4.6%stock +2.7% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 14, 2024EPS missed -17.8%stock +1.8% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was ASND's earnings move already priced in?
ASND's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does ASND hold its opening gap after earnings?
ASND's opening move after each report and where it closed that day.
In 10 reports ASND opened at least 1% away from the previous close. It gave back half or more of that gap by the close 6 of 10 times (60%), and fully reversed 4 times. Gaps up faded 2 of 3; gaps down recovered 4 of 7.
- Aug 13, 2026HeldOpened -2.0%, closed -3.6%
- May 7, 2026ReversedOpened -5.3%, closed +4.3%
- Feb 11, 2026FadedOpened -4.7%, closed -1.5%
- Nov 12, 2025ReversedOpened -3.5%, closed +3.6%
- Aug 7, 2025FadedOpened +3.8%, closed +0.6%
- Feb 12, 2025HeldOpened +10.0%, closed +13.0%
- Nov 14, 2024ReversedOpened -4.3%, closed +1.8%
- Sep 3, 2024HeldOpened -13.1%, closed -11.3%
ASND earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Before open | $0.77 | $0.90 | sources differ | -3.61% | -3.16% |
| May 7, 2026 | Before open | -$0.08 | $0.27 | sources differ | +4.34% | +1.17% |
| Feb 11, 2026 | After close | -$0.24 | -$0.55 | -129.2% | -1.53% | +0.87% |
| Nov 12, 2025 | After close | -$0.12 | -$1.00 | -733.3% | +3.63% | +8.70% |
| Aug 7, 2025 | After close | -$1.26 | -$0.64 | +49.2% | +0.60% | +2.96% |
| May 1, 2025 | After close | -$1.51 | -$1.58 | -4.6% | +2.74% | -2.76% |
| Feb 12, 2025 | After close | -$1.17 | -$0.64 | +45.3% | +12.96% | +23.82% |
| Nov 14, 2024 | After close | -$1.46 | -$1.72 | -17.8% | +1.79% | +0.13% |
| Sep 3, 2024 | After close | -$1.34 | -$1.91 | -42.5% | -11.27% | -11.53% |
| May 2, 2024 | After close | -$1.42 | -$2.30 | -62.0% | -2.76% | -3.63% |
| Feb 7, 2024 | After close | -$1.76 | -$1.54 | +12.5% | -0.03% | +3.81% |
| Nov 7, 2023 | After close | -$2.25 | -$2.88 | -28.0% | -1.47% | -6.11% |
Consensus for the next report: EPS $0.97, revenue $374.97M.
ASND Earnings FAQ
Answers computed from Ascendis Pharma A/S's reported history
ASND is scheduled to report on Nov 9, 2026, after the market closes. Analysts expect EPS of $0.97.
Over the last 10 quarters with a usable EPS surprise, ASND beat the consensus estimate 3 times (30%), missed 7 and landed in line 0. It has missed estimates in each of the last 2 counted quarters. 2 quarters where our data sources disagree on beat versus miss are shown but not counted.
Across its last 12 quarters with a measured reaction, ASND moved an average of ±3.9% in the first session after reporting. It closed higher 50% of the time; the largest gain was 13.0% and the largest drop -11.3%.
Across its last 12 quarters with price data, ASND moved an average of +1.3% in the 20 trading sessions before reporting and was higher in 58% of them. After a run-up of 3% or more (3 quarters), it fell the next day 33% of the time, averaging -2.6%. After a drop of 3% or more (4 quarters), it rose the next day 50% of the time, averaging +2.6%. This describes past reports; it is not a forecast.
In 10 reports ASND opened at least 1% away from the previous close. It gave back half or more of that gap by the close 6 of 10 times (60%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · ASND: 12 reported quarters, latest Aug 13, 2026. Information only, not investment advice.
Looking for more on ASND?
Price charts, forecast, fundamentals and risk pages for ASND are not on Tickzen yet. You can run a full stock analysis now.
Run the ASND Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun